Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer.
AuthorGardner, Kirby P
Adams, Daniel L
JournalInternational Journal of Molecular Sciences
MetadataShow full item record
AbstractThe usage of beta blockers in breast cancer (BC) patients is implicated in the reduction in distant metastases, cancer recurrence, and cancer mortality. Studies suggest that the adrenergic pathway is directly involved in sympathetic-driven hematopoietic activation of pro-tumor microenvironmental proliferation and tumor cell trafficking into the circulation. Cancer-associated macrophage-like cells (CAMLs) are pro-tumor polynucleated monocytic cells of hematopoietic origin emanating from tumors which may aid in circulating tumor cell (CTC) dissemination into the circulation. We examined the linkage between Beta-2 adrenergic receptor (B2AR) signaling in CAMLs and CTCs by establishing expression profiles in a model BC cell line (MDA-MB-231). We compared the model to CAMLs and CTCs found in patents. Although internalization events were observed in patients, differences were found in the expression of B2AR between the tumor cell lines and the CAMLs found in patients. High B2AR expression on patients' CAMLs was correlated with significantly more CAMLs in the circulation (p = 0.0093), but CTCs had no numerical relationship (p = 0.1565). High B2AR CAML expression was also significantly associated with a larger size of CAMLs (p = 0.0073), as well as being significantly associated with shorter progression-free survival (p = 0.0097) and overall survival (p = 0.0265). These data suggest that B2AR expression on CAMLs is closely related to the activation, intravasation, and growth of CAMLs in the circulation.
Data AvailibilityThe data for this study have been made available at: https://doi.org/10.6084/m9.figshare.20188145.v1
Data / Code Locationhttps://doi.org/10.6084/m9.figshare.20188145.v1
Keywordbeta-2 adrenergic receptor
cancer-associated macrophage-like cells
circulating tumor cells
epithelial-to-mesenchymal transition cells
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19345
- Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
- Authors: Mu Z, Wang C, Ye Z, Rossi G, Sun C, Li L, Zhu Z, Yang H, Cristofanilli M
- Issue date: 2017 Oct
- Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
- Authors: Mu Z, Benali-Furet N, Uzan G, Znaty A, Ye Z, Paolillo C, Wang C, Austin L, Rossi G, Fortina P, Yang H, Cristofanilli M
- Issue date: 2016 Sep 30
- CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.
- Authors: Gardner KP, Tsai S, Aldakkak M, Gironda S, Adams DL
- Issue date: 2022
- Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab.
- Authors: Augustyn A, Adams DL, He J, Qiao Y, Verma V, Liao Z, Tang CM, Heymach JV, Tsao AS, Lin SH
- Issue date: 2021 May
- Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
- Authors: Kuvendjiska J, Pitman MB, Martini V, Braun C, Grebe K, Timme S, Fichtner-Feigl S, Glatz T, Schmoor C, Guenzle J, Hoeppner J, Kulemann B
- Issue date: 2020 Oct